HomeInsightsStock Comparison

Kobo Biotech Ltd vs Zenlabs Ethica Ltd Stock Comparison

Kobo Biotech Ltd vs Zenlabs Ethica Ltd Stock Comparison

Last Updated on: Jun 25, 2025

Key Highlights

  • The Latest Trading Price of Kobo Biotech Ltd is ₹ 2.48 as of 24 Jun 15:30.
  • The P/E Ratio of Kobo Biotech Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Zenlabs Ethica Ltd changed from 17.9 on March 2021 to 63.8 on March 2024 . This represents a CAGR of 37.40% over 4 years.
  • The Market Cap of Kobo Biotech Ltd changed from ₹ 6.89 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Zenlabs Ethica Ltd changed from ₹ 23.7 crore on March 2020 to ₹ 27.02 crore on March 2024 . This represents a CAGR of 2.66% over 5 years.
  • The revenue of Kobo Biotech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Zenlabs Ethica Ltd for the Mar '25 is ₹ 13.03 crore as compare to the Dec '24 revenue of ₹ 12.73 crore. This represent the growth of 2.36%.
  • The ebitda of Kobo Biotech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Zenlabs Ethica Ltd for the Mar '25 is ₹ 0.7 crore as compare to the Dec '24 ebitda of ₹ 0.68 crore. This represent the growth of 2.94%.
  • The net profit of Kobo Biotech Ltd changed from ₹ -1.23 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Zenlabs Ethica Ltd changed from ₹ 0.07 crore to ₹ 0.09 crore over 8 quarters. This represents a CAGR of 13.39% .
  • The Dividend Payout of Kobo Biotech Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zenlabs Ethica Ltd changed from 33.21 % on March 2023 to 0 % on March 2024 . This represents a CAGR of -100.00% over 2 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Kobo Biotech Ltd

  • Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
  • Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
  • The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.

About Zenlabs Ethica Ltd

  • Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993.
  • The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network.
  • It deals into marketing and distribution of pharmaceutical products and has grown to be of India's top pharmaceutical companies in 2019. The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
  • The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people.
  • Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.

Kobo Biotech Ltd News Hub

News

Kobo Biotech to discuss results

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 14 August 202...

Read more

13 Aug 2024 10:21

News

Kobo Biotech to convene board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 30 May 2024 P...

Read more

28 May 2024 15:31

News

Kobo Biotech to conduct board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2...

Read more

09 Feb 2024 14:57

News

Kobo Biotech to hold board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 10 November 2...

Read more

03 Nov 2023 17:17

News

Kobo Biotech to hold AGM

Kobo Biotech announced that the 30th Annual General Meeting (AGM) of the company will be h...

Read more

09 Sep 2023 18:44

News

Kobo Biotech to declare Quarterly Result

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 11 August 202...

Read more

07 Aug 2023 13:02

Zenlabs Ethica Ltd News Hub

News

Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025...

Read more

08 May 2025 11:05

News

Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025...

Read more

07 May 2025 11:07

News

Zenlabs Ethica to hold board meeting

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 February ...

Read more

31 Jan 2025 15:48

News

Zenlabs Ethica to announce Quarterly Result

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 November...

Read more

07 Nov 2024 16:58

News

Zenlabs Ethica AGM scheduled

Zenlabs Ethica announced that the 31th Annual General Meeting (AGM) of the company will be...

Read more

30 Sep 2024 10:04

News

Zenlabs Ethica announces board meeting date

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 August 20...

Read more

02 Aug 2024 10:30

SWOT Analysis Of Zenlabs Ethica Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Kobo Biotech Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Zenlabs Ethica Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Kobo Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Kobo Biotech Ltd and Zenlabs Ethica Ltd

Which company has a larger market capitalization, Kobo Biotech Ltd or Zenlabs Ethica Ltd?

Market cap of Kobo Biotech Ltd is 5 Cr while Market cap of Zenlabs Ethica Ltd is 21 Cr

What are the key factors driving the stock performance of Kobo Biotech Ltd and Zenlabs Ethica Ltd?

The stock performance of Kobo Biotech Ltd and Zenlabs Ethica Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kobo Biotech Ltd and Zenlabs Ethica Ltd?

As of June 25, 2025, the Kobo Biotech Ltd stock price is INR ₹2.48. On the other hand, Zenlabs Ethica Ltd stock price is INR ₹32.31.

How do dividend payouts of Kobo Biotech Ltd and Zenlabs Ethica Ltd compare?

To compare the dividend payouts of Kobo Biotech Ltd and Zenlabs Ethica Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions